Drug Patent Expirations in March 2012

Drug Patent Expirations in March 2012

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
GEODON Pfizer ziprasidone mesylate 4,831,031 Mar 2, 2012
GEODON Pfizer Inc ziprasidone hydrochloride 4,831,031 Mar 2, 2012
GEODON Pfizer ziprasidone hydrochloride 4,831,031 Mar 2, 2012
ZOFRAN Glaxosmithkline ondansetron hydrochloride 5,344,658*PED Mar 6, 2012
GENESA Gensia Automedics arbutamine hydrochloride 5,395,970 Mar 7, 2012
NUTROPIN DEPOT Genentech somatropin recombinant 5,912,015 Mar 12, 2012
LEXAPRO Forest Labs escitalopram oxalate RE34712*PED Mar 14, 2012
AVANDIA Sb Pharmco rosiglitazone maleate 5,002,953*PED Mar 17, 2012
AVANDAMET Sb Pharmco metformin hydrochloride; rosiglitazone maleate 5,002,953*PED Mar 17, 2012
AVANDARYL Sb Pharmco glimepiride; rosiglitazone maleate 5,002,953*PED Mar 17, 2012
BONIVA Roche ibandronate sodium 4,927,814 Mar 17, 2012
ERAXIS Vicuron anidulafungin 6,384,013 Mar 19, 2012
ERAXIS Vicuron anidulafungin 6,743,777 Mar 19, 2012
VALTURNA Novartis aliskiren hemifumarate; valsartan 5,399,578 Mar 21, 2012
GABITRIL Cephalon tiagabine hydrochloride 5,354,760 Mar 24, 2012
SEROQUEL Astrazeneca quetiapine fumarate 4,879,288*PED Mar 26, 2012
SEROQUEL XR Astrazeneca quetiapine fumarate 4,879,288*PED Mar 26, 2012
NUEDEXTA Avanir Pharms dextromethorphan hydrobromide; quinidine sulfate 5,206,248 Mar 27, 2012
FLOXIN OTIC Daiichi ofloxacin 5,401,741 Mar 27, 2012
AVALIDE Sanofi Aventis hydrochlorothiazide; irbesartan 5,270,317*PED Mar 30, 2012
AVAPRO Sanofi Aventis Us irbesartan 5,270,317*PED Mar 30, 2012

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com


Leave a Reply